瓦博格效应
线粒体
癌症
癌症研究
癌细胞
程序性细胞死亡
生物
细胞代谢
恶性肿瘤
新陈代谢
细胞
细胞凋亡
肿瘤细胞
癌症治疗
能量代谢
生物信息学
细胞代谢
细胞生长
细胞生物学
癌症治疗
机制(生物学)
营养感应
治疗窗口
代谢途径
计算生物学
肿瘤微环境
平衡
恶性细胞
肿瘤进展
治疗方法
联动装置(软件)
靶向治疗
作者
Jillian Weissenrieder,J. Kevin Foskett
摘要
ABSTRACT Cancer is a leading cause of death in developed countries, despite many breakthroughs in targeted small molecule and immunotherapeutic interventions. A deeper understanding of the characteristics and processes that underlie malignancy will enable us to develop more effective therapeutic options to improve patient outcomes. One particular area of interest is in cancer cell metabolism. Even as early as the 1920s, Otto Warburg recognized dysregulated metabolism in cancerous cells. Altered metabolism may provide targetable nutrient dependencies for further clinical development, either by nutrient restriction or pathway inhibition. More recently, researchers have observed an increasingly strong linkage between altered mitochondrial Ca 2+ homeostasis and tumor cell metabolism, with strong implications for therapeutic targeting. In this review, we summarize the literature surrounding mitochondrial Ca 2+ homeostasis, metabolism, and cancer, as well as providing a discussion of the potential for mitochondrial Ca 2+ modulation as an anticancer therapeutic modality.
科研通智能强力驱动
Strongly Powered by AbleSci AI